NCT00448071View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

March 31, 2007

Conditions
HypotensionEnd Stage Renal DiseaseIntra Dialytic Hypotension
Interventions
DRUG

MTR107

Trial Locations (2)

58100

RECRUITING

Wolfson Medical Center, Holon

70300

RECRUITING

Asaf Harofeh Medical Center, Rishon LeZiyyon

Sponsors
All Listed Sponsors
collaborator

Meditor Pharmaceuticals Ltd.

INDUSTRY

lead

Wolfson Medical Center

OTHER_GOV

NCT00448071 - Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients | Biotech Hunter | Biotech Hunter